GlassScriptPhysician profile
George Juan
NPI 1619273364
$8,983.57
in general payments reported to CMS, 2019-2025
33 companies · $1,044 in 2025
The $1,044 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $210 · 2022: $1,261 · 2023: $2,028 · 2024: $3,954 · 2025: $1,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,502 · Education: $2,500 · Travel and Lodging: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,502.11 |
| Education | $2,500.00 |
| Travel and Lodging | $1,024.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,051.77 | 2022-2025 | Da Vinci Surgical System |
| Pulmonx Corporation | $1,694.13 | 2023-2025 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Astrazeneca Pharmaceuticals LP | $558.22 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Inspire Medical Systems, INC. | $341.45 | 2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $258.49 | 2019-2025 | Ofev |
| Glaxosmithkline, LLC. | $176.07 | 2019-2025 | Trelegy Ellipta |
| Actelion Pharmaceuticals US, INC. | $174.47 | 2019-2025 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $152.63 | 2019-2023 | Recarbrio, Zerbaxa |
| Coaptech, INC. | $147.64 | 2023 | Puma System |
| Siemens Medical Solutions USA, INC. | $143.18 | 2024 | Cios Spin |
| Verona Pharma, INC. | $139.02 | 2025 | Ohtuvayre |
| Galvanize Therapeutics, INC | $134.50 | 2024 | Aliya System |
| Ethicon INC. | $118.15 | 2023 | Monarch Platform |
| Erbe USA INC | $118.00 | 2024 | Cryo2 |
| Baxter Healthcare | $92.49 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $84.86 | 2019-2025 | |
| Pinnacle Biologics, INC | $80.00 | 2025 | Photofrin |
| Takeda Pharmaceuticals U.S.A., INC. | $53.09 | 2025 | Glassia, Cuvitru |
| Viatris Specialty LLC | $47.30 | 2025 | Yupelri |
| Janssen Pharmaceuticals, INC | $46.53 | 2020-2022 | |
| Grifols USA, LLC | $43.50 | 2023-2024 | Prolastin-C Liquid |
| Inari Medical, INC. | $39.69 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $38.46 | 2025 | |
| Mylan Specialty L.P. | $37.45 | 2019-2023 | Yupelri |
| Circassia INC. | $37.17 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $33.90 | 2025 | Dupixent |
| Abbvie INC. | $26.42 | 2022 | |
| Amgen INC. | $23.07 | 2023 | Tezspire |
| United Therapeutics Corporation | $20.13 | 2019 | |
| Advanced Respiratory, INC | $20.11 | 2020 | |
| Philips North America LLC | $17.52 | 2019 | |
| Genzyme Corporation | $17.21 | 2025 | |
| Lilly USA, LLC | $16.95 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Juan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.